(Q51579395)

7 April 2018

title

Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians. (English)

1 reference

7 April 2018

1 reference

1 reference

1 reference

Nagi DK

1

1 reference

7 April 2018

Tracy R

series ordinal

2

1 reference

7 April 2018

Pratley R

series ordinal

3

1 reference

7 April 2018

publication date

1 October 1996

1 reference

7 April 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

7 April 2018

volume

45

1 reference

7 April 2018

issue

10

1 reference

7 April 2018

page(s)

1243-1247

1 reference

7 April 2018

Banting lecture 1988. Role of insulin resistance in human disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Increased in vivo insulin resistance in nondiabetic Pima Indians compared with Caucasians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Coated Charcoal Immunoassay of Insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Short-term infusions of insulin, triacylglycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990242-5

10.1016/S0026-0495(96)90242-5

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018